Jefferies Healthcare Conference
June 5, 2024
New York
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Goldman Sachs 45th Annual Global Healthcare Conference
June 12, 2024
Miami
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Past events
J.P. Morgan 41st Annual Healthcare Conference 2023 San Francisco
January 9 to 11, 2023
San Francisco
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Conference Call & Webcast – CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs
January 6, 2023
CureVac N.V. (Nasdaq: CVAC) today announced positive preliminary data from ongoing Phase 1 clinical programs in COVID-19 and seasonal flu, assessing both modified and unmodified mRNA technology.
The company hosted a conference call and webcast. Please find below the download link for the press release and the presentation slides as well as the link to the on demand version of the webcast.
The JMP Securities Hematology and Oncology Summit
December 6, 2022
Virtual
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
5th Annual Evercore ISI HealthCONx Conference
November 29, 2022
Virtual
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Jefferies London Healthcare Conference
November 17, 2022
London
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Third Quarter and First Nine Months 2022 Financial Results and Business Updates – Conference Call & Webcast
November 16, 2022
CureVac N.V. (Nasdaq: CVAC) has reported financial results and provided business updates for the third quarter and first nine months of 2022 on Wednesday, November 16, 2022. The company hosted a conference call and webcast on the same day.
Please find the corresponding press release and presentation slides below. A link to the replay of the webcast will be made available shortly.
10th International mRNA Health Conference
November 8-10, 2022
Boston
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Links
Berenberg and Goldman Sachs Eleventh German Corporate Conference
September 20, 2022
Munich
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Links
Morgan Stanley 20th Annual Global Healthcare Conference
September 12, 2022
New York
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Links
Annual General Meeting of Shareholders
June 22, 2022
Amsterdam
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
The JMP Securities Life Sciences Conference
June 15, 2022
New York
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Jefferies Healthcare Conference
June 9, 2022
New York
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Links
UBS – 2022 Global Healthcare Conference
June 1, 2022
Virtual
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Links
BofA Securities 2022 Healthcare Conference
May 10, 2022
Las Vegas
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Links
Fourth Quarter and Full-Year 2021 Financial Results and Business Updates – Conference Call & Webcast
April 28, 2022
CureVac N.V. (Nasdaq: CVAC) has reported financial results, and provided business updates for the fourth quarter and full-year 2021 on Thursday, April 28, 2022. On the same day, the company hosted a conference call and webcast.
Please find the corresponding press release and presentation slides below. An archived webcast will also be made available through the same link on the CureVac website shortly.
Downloads
Links